Find Thiamylal manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Sodium thiamylal, Thiamylal sodium salt, 337-47-3, Surital sodium salt, Ncgc00095772-01, 5-allyl-5-(1-methylbutyl)-2-thiobarbituric acid, sodium salt
Molecular Formula
C12H17N2NaO2S
Molecular Weight
276.33  g/mol
InChI Key
LYZGJWXNOGIVQA-UHFFFAOYSA-M

Thiamylal
A barbiturate that is administered intravenously for the production of complete anesthesia of short duration, for the induction of general anesthesia, or for inducing a hypnotic state. (From Martindale, The Extra Pharmacopoeia, 30th ed, p919)
1 2D Structure

Thiamylal

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;4,6-dioxo-5-pentan-2-yl-5-prop-2-enyl-1H-pyrimidine-2-thiolate
2.1.2 InChI
InChI=1S/C12H18N2O2S.Na/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16;/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17);/q;+1/p-1
2.1.3 InChI Key
LYZGJWXNOGIVQA-UHFFFAOYSA-M
2.1.4 Canonical SMILES
CCCC(C)C1(C(=O)NC(=NC1=O)[S-])CC=C.[Na+]
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Sodium, Thiamylal

2. Surital

3. Thiamylal

4. Thioquinalbarbitone

2.2.2 Depositor-Supplied Synonyms

1. Sodium Thiamylal

2. Thiamylal Sodium Salt

3. 337-47-3

4. Surital Sodium Salt

5. Ncgc00095772-01

6. 5-allyl-5-(1-methylbutyl)-2-thiobarbituric Acid, Sodium Salt

7. Surital Sodium

8. Thiomylal Sodium

9. Sodium 5-allyl-5-(1-methylbutyl)-2-thiobarbiturate

10. Thioseconal Sodium

11. T4l2p3kh7k

12. 5-allyl-5-(1-methylbutyl)-2-thiobarbituric Acid, Sodium Derivative

13. Surital Sodium Deriv.

14. Nsc-759558

15. 4,6-(1h,5h)-pyrimidinedione, Dihydro-5-(1-methylbutyl)-5-(2-propenyl)-2-thioxo-, Monosodium Salt

16. Einecs 206-415-5

17. Unii-t4l2p3kh7k

18. Thiamylal Sodium [usp:jan]

19. Surital (tn)

20. 5-allyl-5-(1-methylbutyl)-2-thiobarbiturate Sodium

21. 5-allyl-5-(1-methylbutyl)-2-thio-barbituric Acid Sodium Salt

22. Thiamylal Sodium (jp17)

23. Dsstox_cid_25988

24. Dsstox_rid_81275

25. Dsstox_gsid_45988

26. Schembl34746

27. Spectrum1900002

28. Chebi:9537

29. Chembl1201065

30. Dtxsid3045988

31. Hms503e21

32. Hms2094g05

33. Tox21_111517

34. Barbituric Acid, 5-allyl-5-(1-methylbutyl)-2-thio-, Sodium Salt

35. Ccg-213640

36. Nsc 759558

37. Ncgc00095772-02

38. 4,6(1h,5h)-pyrimidinedione, Dihydro-5-(1-methylbutyl)-5-(2-propenyl)-2-thioxo-, Monosodium Salt

39. Cas-337-47-3

40. D00713

41. Q27289664

2.3 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 276.33 g/mol
Molecular Formula C12H17N2NaO2S
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count5
Exact Mass276.09084324 g/mol
Monoisotopic Mass276.09084324 g/mol
Topological Polar Surface Area59.5 Ų
Heavy Atom Count18
Formal Charge0
Complexity384
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anesthetics, Intravenous

Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)


GABA Modulators

Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)


Hypnotics and Sedatives

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)


Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty